|
Sign In to gain access to subscriptions and/or personal tools.
|
Cytokine expression in lupus kidneys
M Aringer
Department of Rheumatology, Medical University of Vienna, Vienna, Austria
J S Smolen
Department of Rheumatology, Medical University of Vienna, Vienna, Austria, martin.aringer{at}meduniwien.ac.at
Although far from complete, the picture of cytokines present in systemic lupus erythematosus (SLE) glomerulonephritis is already complex. Proinflammatory cytokines, such as TNF, IL-6, IL-1, and IL-18 are upregulated, as are both Th1 and Th2 cytokines, with different implications. In many instances, the local effects may be different from the systemic immunoregulatory ones. For some proinflammatory cytokines, and TNF in particular, the local proinflammatory ones may be more relevant to the disease. This may help solve discrepancies between different murine models of the disease and provide a better rationale for targeting certain cytokines in human SLE.
Key Words: fibrosis • glomerulonephritis • inflammation • lupus • renal cytokines
Lupus, Vol. 14, No. 1,
13-18 (2005)
DOI: 10.1191/0961203305lu2053oa
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
B. H. Rovin and X. Zhang
Biomarkers for Lupus Nephritis: The Quest Continues
Clin. J. Am. Soc. Nephrol.,
November 1, 2009;
4(11):
1858 - 1865.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Aringer, F. Houssiau, C. Gordon, W. B. Graninger, R. E. Voll, E. Rath, G. Steiner, and J. S. Smolen
Adverse events and efficacy of TNF-{alpha} blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients
Rheumatology,
November 1, 2009;
48(11):
1451 - 1454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. H. Rovin, A. M. McKinley, and D. J. Birmingham
Can We Personalize Treatment for Kidney Diseases?
Clin. J. Am. Soc. Nephrol.,
October 1, 2009;
4(10):
1670 - 1676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Zhu, X Yang, Y Ji, W Chen, W Guan, S. Zhou, and X Yu
Up-regulated renal expression of TNF-{alpha} signalling adapter proteins in lupus glomerulonephritis
Lupus,
February 1, 2009;
18(2):
116 - 127.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M Aringer and J. Smolen
TNF inhibition in SLE: where do we stand?
Lupus,
January 1, 2009;
18(1):
5 - 8.
[PDF]
|
|
|
|
|
|
|
H.-C. Chuang, J.-M. Wang, W.-C. Hsieh, Y. Chang, and I.-J. Su
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr Virus Infection and Immune Disorders
Am. J. Pathol.,
November 1, 2008;
173(5):
1397 - 1405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Hong, T. Wang, C. Huang, W. Cheng, and B. Lin
Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice
Lupus,
September 1, 2008;
17(9):
814 - 821.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T.-C. Hsu, S.-Y. Chiang, C.-Y. Huang, G. J. Tsay, C.-W. Yang, C.-N. Huang, and B.-S. Tzang
Beneficial Effects of Treatment with Transglutaminase Inhibitor Cystamine on Macrophage Response in NZB/W F1 Mice
Experimental Biology and Medicine,
February 1, 2007;
232(2):
195 - 203.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Ryan and G. R. McLemore Jr.
Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2007;
292(2):
R736 - R742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M DeBandt
Lessons for lupus from tumour necrosis factor blockade
Lupus,
November 1, 2006;
15(11):
762 - 767.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. V. Navarra
Immune therapy of lupus: what is on the horizon?
Nephrol. Dial. Transplant.,
March 1, 2006;
21(3):
579 - 581.
[Full Text]
[PDF]
|
|
|
|
|
